Literature DB >> 23117546

Rare double heterozygous mutations in antithrombin underlie hereditary thrombophilia in a Chinese family.

Haoyu Deng1, Jiaquan Chen, Hui Xie, Yi Gu, Kai Yuan, Peng Wang, Wei Shen, Wei Liang, Hao Zhang, Jiwei Zhang, Jun Xie, Lan Zhang.   

Abstract

VTE is a complex disorder with two main manifestations: DVT and PE. Deficiency of natural anticoagulants plays an important role in the pathogenesis of VTE. Antithrombin (AT) deficiency is one of the most common hereditary thrombophilia in Asia. Subjects with AT deficiency have two mutations in the same allele of the SERPINC1 gene: p.Arg45Gln and p.Ser114Arg (Arg13Gln and Ser82Arg, according to the antithrombin mutation database). DNA sequencing, ELISA (enzyme-linked immuno sorbent assay), plasmid transfection, and homology modeling were performed to study the molecular pathophysiological mechanism of the deficiency. Recombinant expression of these mutations demonstrated a relevant functional effect on the p.Ser114Arg mutation, since it almost abolished the secretion of AT to the conditioned medium and increased intracellular retention, while the p.Arg45Gln mutation had negligible effects. Homology modeling showed that some atoms from Arg114 interfered with the atoms of the β-strand, the abstract power between Arg45 and S2 was larger than that between Gln45 and S2, and the electrostatic energy (-617.281 to -452.079 K) was the primary contributor to this difference. The functional mutation responsible for the deficiency of this potent anticoagulant p.Ser114Arg probably has conformational consequences on the folding of the protein leading to its intracellular accumulation and impaired secretion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23117546     DOI: 10.1007/s11239-012-0822-7

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  15 in total

1.  Creation of an additional glycosylation site as a mechanism for type I antithrombin deficiency.

Authors:  A C Fitches; K Lewandowski; R J Olds
Journal:  Thromb Haemost       Date:  2001-10       Impact factor: 5.249

2.  High prevalence of antithrombin III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan.

Authors:  M C Shen; J S Lin; W Tsay
Journal:  Thromb Res       Date:  1997-08-15       Impact factor: 3.944

3.  Three case reports of inherited antithrombin deficiency in China: double novel missense mutations, a nonsense mutation and a frameshift mutation.

Authors:  Haoyu Deng; Wei Shen; Yi Gu; Xiong Ma; Jiwei Zhang; Lan Zhang
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

4.  Thrombosis as a conformational disease.

Authors:  Javier Corral; Vicente Vicente; Robin W Carrell
Journal:  Haematologica       Date:  2005-02       Impact factor: 9.941

5.  Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.

Authors:  Vincenza Snow; Amir Qaseem; Patricia Barry; E Rodney Hornbake; Jonathan E Rodnick; Timothy Tobolic; Belinda Ireland; Jodi B Segal; Eric B Bass; Kevin B Weiss; Lee Green; Douglas K Owens
Journal:  Ann Intern Med       Date:  2007-01-29       Impact factor: 25.391

6.  Novel mutation (E113X) of antithrombin III gene (AT3) in a woman with gestational recurrent thrombosis.

Authors:  H Yamada; N Hoshi; E H Kato; Y Ebina; T Kishida; T Sagawa; K Matsuno; S Fujimoto
Journal:  Am J Med Genet       Date:  2000-04-24

7.  Roles of N-terminal region residues Lys11, Arg13, and Arg24 of antithrombin in heparin recognition and in promotion and stabilization of the heparin-induced conformational change.

Authors:  Sophia Schedin-Weiss; Umesh R Desai; Susan C Bock; Steven T Olson; Ingemar Björk
Journal:  Biochemistry       Date:  2004-01-27       Impact factor: 3.162

8.  Introduction of a mutation in the shutter region of antithrombin (Phe77 --> Leu) increases affinity for heparin and decreases thermal stability.

Authors:  Noelene S Quinsey; Hazel L Fitton; Paul Coughlin; James C Whisstock; Timothy R Dafforn; Robin W Carrell; Stephen P Bottomley; Robert N Pike
Journal:  Biochemistry       Date:  2003-09-02       Impact factor: 3.162

9.  High incidence of thrombophilia detected in Chinese patients with venous thrombosis.

Authors:  H W Liu; Y L Kwong; C Bourke; C K Lam; A K Lie; D Wei; L C Chan
Journal:  Thromb Haemost       Date:  1994-04       Impact factor: 5.249

10.  Antithrombins Wibble and Wobble (T85M/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation.

Authors:  N J Beauchamp; R N Pike; M Daly; L Butler; M Makris; T R Dafforn; A Zhou; H L Fitton; F E Preston; I R Peake; R W Carrell
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113

View more
  1 in total

1.  Deficiencies of the Natural Anticoagulants - Novel Clinical Laboratory Aspects of Thrombophilia Testing.

Authors:  Zsuzsanna Bereczky; Réka Gindele; Marianna Speker; Judit Kállai
Journal:  EJIFCC       Date:  2016-04-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.